OOIR: Observatory of International Research

Papers

(The TQCC of Journal of Medical Screening is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Introduction of one-view tomosynthesis in population-based mammography screening: Impact on detection rate, interval cancer rate and false-positive rate	56
Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey	35
Lymphoproliferative disease detected by breast cancer screening	25
Couple screening for recessively inherited disorders	24
NHS announces a pilot of a blood test for early detection of many cancers	22
Cell-free DNA-based prenatal screening via rolling circle amplification: Identifying and resolving analytic issues	22
Interval cancer audit and disclosure in breast screening programmes: An international survey	20
Acceptability of alternative technologies compared with faecal immunochemical test and/or colonoscopy in colorectal cancer screening: A systematic review	18
Comparison of cytology and human papillomavirus-based primary testing in cervical screening programs in the Nordic countries	17
Newborn screening for biliary atresia using direct bilirubin: An implementation science study	13
Validation of a monoclonal unconjugated estriol antibody for use in prenatal maternal serum screening	11
Detection and significance of small and low proliferation breast cancer	11
“It's cancer screening after all”. Barriers to cervical and colorectal cancer screening and attitudes to promotion of self-sampling kits upon attendance for breast cancer screening	10
Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: A rapid review and meta-analysis	10
Evaluation of the Call for a Kit intervention to increase bowel cancer screening uptake in Lancashire, England	10
HPV self-sampling and follow-up over two rounds of cervical screening in Australia – the iPap trial	9
Assessment of breast positioning criteria in mammographic screening: Agreement between artificial intelligence software and radiographers	9
Effects of health education on screening rate of first-degree relatives of cancer patients: A systematic review and meta-analysis	9
The impact of age at initial HPV vaccination on cervical cancer screening participation in a nationally representative cohort of women in the United States	9
Identifying optimum implementation for human papillomavirus self-sampling in underserved communities: A systematic review	9
Impact of COVID-19-related care disruptions on cervical cancer screening in the United States	8
Combining genetic and non-genetic risk factors to predict disease, and reporting the screening performance of risk models	8
Factors associated with women's supplemental screening intentions following dense breast notification in an online randomised experimental study	8
Estimating stage-specific sensitivity for cancer screening tests	8
Racial/ethnic and socioeconomic disparities in colorectal cancer screening in a large organization with universal insurance before and during the coronavirus disease 2019 pandemic	7

When primary prevention replaces screening	7
Association between time to colonoscopy after positive fecal testing and colorectal cancer outcomes in Alberta, Canada	7
Newborn screening for inherited metabolic diseases using tandem mass spectrometry in China: Outcome and cost–utility analysis	6
Optimising recruitment to a lung cancer screening trial: A comparison of general practitioner and community-based recruitment	6
Artificial intelligence for triaging of breast cancer screening mammograms and workload reduction: A meta-analysis of a deep learning software	5
Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women	5
Overview of organisational methods of primary cervical lesion screening programmes that use human papillomavirus testing	5
Prenatal serum screening for Down syndrome and neural tube defects in the United States: Changes in utilization patterns from 2012 to 2020	5
Colonoscopy may be weak link in organised colorectal cancer screening programme with faecal immunochemical test	5
Availability of data for cost-effectiveness comparison of child vision and hearing screening programmes	4
Are screening practice ethics committees needed?	4
Risk stratification in medical screening	4
Age at breast cancer screening in women with intellectual disability	4
Impact of cumulative experience on the quality of screening colonoscopy: A 13-year observational study	4
Google search volume trends for cancer screening terms during the COVID-19 pandemic	4
The randomized trial of mammography screening that was not—A cautionary tale	3
Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland	3
Simulated arbitration of discordance between radiologists and artificial intelligence interpretation of breast cancer screening mammograms	3
Wide variability in colorectal cancer screening uptake by general practitioner: Cross-sectional study	3
Breast cancer mortality after eight years of an improved screening program using digital breast tomosynthesis	3
Long-term colorectal cancer incidence in a post-endoscopic screening cohort, accounting for surveillance, by baseline polyp group, anatomic subsite, and sex	3
Trends in colorectal cancer screening in the United States, 2012 to 2020	3